{"id":"NCT02875834","sponsor":"AstraZeneca","briefTitle":"A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia","officialTitle":"A Phase 3 Multicenter, Prospective, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of ZS, in Patients With Hyperkalemia-HARMONIZE Global","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-03","primaryCompletion":"2018-02-14","completion":"2018-02-14","firstPosted":"2016-08-23","resultsPosted":"2020-08-19","lastUpdate":"2020-08-19"},"enrollment":267,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hyperkalemia"],"interventions":[{"type":"DRUG","name":"Sodium Zirconium Cyclosilicate (ZS) 10g","otherNames":[]},{"type":"DRUG","name":"Sodium Zirconium Cyclosilicate (ZS) 5g","otherNames":[]},{"type":"DRUG","name":"Sodium Zirconium Cyclosilicate (ZS) 10g","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sodium Zirconium Cyclosilicate (ZS) 5g","type":"EXPERIMENTAL"},{"label":"Sodium Zirconium Cyclosilicate (ZS) 10g","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy of two different doses (5 and 10 g) of ZS orally administered once daily (qd) vs placebo in maintaining normokalemia in initially hyperkalemic patients having achieved normokalemia following two days of initial ZS therapy (10g TID).","primaryOutcome":{"measure":"Least Square Mean S-K Level on Days 8-29","timeFrame":"Through 28-day randomized treatment study phase day 8-29.","effectByArm":[{"arm":"Sodium Zirconium Cyclosilicate (ZS) 5g","deltaMin":4.811,"sd":null},{"arm":"Sodium Zirconium Cyclosilicate (ZS) 10g","deltaMin":4.381,"sd":null},{"arm":"Placebo","deltaMin":5.321,"sd":null}],"pValues":[{"comp":"OG001 vs OG003","p":"<0.001"},{"comp":"OG002 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":45,"countries":["Japan","Russia","South Korea","Taiwan"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4401&filename=d9480c00002-sap-ed-2_Redacted_CTT.PDF","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4401&filename=d9480c00002-csp-v3_Redacted_CTT.PDF"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":267},"commonTop":["Oedema peripheral","Constipation","Oedema"]}}